Cargando…
Treatment of patients with Covid-19 with a high dose of ulinastatin
Currently, there are no specific therapeutic agents available for the treatment of coronavirus disease 2019 (Covid-19). The present study aimed to assess the efficacy of high-dose ulinastatin for the treatment of patients with Covid-19. A total of 12 patients hospitalized with confirmed severe acute...
Autores principales: | Huang, Hai, Hu, Ping-Fang, Sun, Liang-Liang, Guo, Yi-Bin, Wang, Qiong, Liu, Zhi-Min, Yin, Ji-Zhong, Shi, Pei-Mei, Yuan, Zong-Li, Xie, Wei-Fen |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8713169/ https://www.ncbi.nlm.nih.gov/pubmed/34970344 http://dx.doi.org/10.3892/etm.2021.11044 |
Ejemplares similares
-
Ulinastatin Exhibits Antinociception in Rat Models of Acute Somatic and Visceral Pain Through Inhibiting the Local and Central Inflammation
por: Zhan, Mei-Xiang, et al.
Publicado: (2021) -
Effects of ulinastatin on global ischemia via brain pro-inflammation
signal
por: Jiang, Xiao-Ming, et al.
Publicado: (2016) -
Evaluation of the Pharmacological Function of Ulinastatin in Experimental Animals
por: Xu, Chong-En, et al.
Publicado: (2012) -
Ulinastatin Suppresses Burn-Induced Lipid Peroxidation and Reduces Fluid Requirements in a Swine Model
por: Luo, Hong-Min, et al.
Publicado: (2013) -
Clinical observation of ulinastatin combined with CRRT in the treatment of early cardiopulmonary resuscitation
por: Liu, Qinghong, et al.
Publicado: (2017)